Bepafant
Alternative Names: STY 2108; WEB 2170Latest Information Update: 14 Aug 1997
At a glance
- Originator Boehringer Ingelheim
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Azepines; Small molecules; Triazoles
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Ischaemic heart disorders; Transplant rejection